JENNIFER PARRISH: Open Payments
NPI 1356395297 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,217 in 105 payments from 22 companies in 2025. Trend: 2023 $2,324 · 2024 $3,167 · 2025 $2,217
Food & beverage: $2,217
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $384 |
| ABBVIE INC. | 26 | $313 |
| PFIZER INC. | 12 | $243 |
| Neurocrine BioSciences, Inc. | 9 | $203 |
| Mallinckrodt Hospital Products Inc. | 7 | $167 |
| Genentech USA, Inc. | 6 | $137 |
| Lundbeck LLC | 4 | $117 |
| SK Life Science, Inc. | 4 | $116 |
| GENZYME CORPORATION | 3 | $79 |
| UCB, Inc. | 2 | $57 |
Products named: UPLIZNA, NURTEC ODT, QULIPTA, INGREZZA, ACTHAR, VYEPTI, Ocrevus Zunovo, UBRELVY.
Industry payments across AL — which companies pay providers there.
